vs

Side-by-side financial comparison of AMPCO PITTSBURGH CORP (AP) and Esperion Therapeutics, Inc. (ESPR). Click either name above to swap in a different company.

Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $104.4M, roughly 1.6× AMPCO PITTSBURGH CORP). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 11.5%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs -2.6%).

Ampco-Pittsburgh Corporation is a specialty steel manufacturer headquartered in Downtown Pittsburgh, Pennsylvania. It is one of several companies to bear the Ampco name, and it should not be confused with the Milwaukee-based copper base alloy producer, Ampco Metal Inc.; the Miami-based cabinetry company; the Swiss aluminum corporation; or the Dallas-based tool company. Ampco was formed in 1929 and is a conglomerate made up of several previously established small steel makers. Five small compa...

Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

AP vs ESPR — Head-to-Head

Bigger by revenue
ESPR
ESPR
1.6× larger
ESPR
$168.4M
$104.4M
AP
Growing faster (revenue YoY)
ESPR
ESPR
+132.3% gap
ESPR
143.7%
11.5%
AP
Faster 2-yr revenue CAGR
ESPR
ESPR
Annualised
ESPR
10.6%
-2.6%
AP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AP
AP
ESPR
ESPR
Revenue
$104.4M
$168.4M
Net Profit
$-57.7M
Gross Margin
Operating Margin
-54.0%
50.6%
Net Margin
-55.2%
Revenue YoY
11.5%
143.7%
Net Profit YoY
-1958.9%
EPS (diluted)
$-2.87
$0.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AP
AP
ESPR
ESPR
Q4 25
$104.4M
$168.4M
Q3 25
$103.7M
$87.3M
Q2 25
$108.9M
$82.4M
Q1 25
$99.2M
$65.0M
Q4 24
$93.6M
$69.1M
Q3 24
$92.1M
$51.6M
Q2 24
$107.1M
$73.8M
Q1 24
$110.0M
$137.7M
Net Profit
AP
AP
ESPR
ESPR
Q4 25
$-57.7M
Q3 25
$-2.2M
$-31.3M
Q2 25
$-7.3M
$-12.7M
Q1 25
$1.1M
$-40.5M
Q4 24
$3.1M
Q3 24
$-2.0M
$-29.5M
Q2 24
$2.0M
$-61.9M
Q1 24
$-2.7M
$61.0M
Operating Margin
AP
AP
ESPR
ESPR
Q4 25
-54.0%
50.6%
Q3 25
1.1%
-11.4%
Q2 25
-2.8%
8.6%
Q1 25
3.9%
-34.0%
Q4 24
5.5%
-6.4%
Q3 24
2.0%
-31.0%
Q2 24
4.7%
3.5%
Q1 24
0.1%
52.5%
Net Margin
AP
AP
ESPR
ESPR
Q4 25
-55.2%
Q3 25
-2.1%
-35.9%
Q2 25
-6.7%
-15.4%
Q1 25
1.2%
-62.2%
Q4 24
3.3%
Q3 24
-2.1%
-57.2%
Q2 24
1.9%
-83.9%
Q1 24
-2.5%
44.3%
EPS (diluted)
AP
AP
ESPR
ESPR
Q4 25
$-2.87
$0.32
Q3 25
$-0.11
$-0.16
Q2 25
$-0.36
$-0.06
Q1 25
$0.06
$-0.21
Q4 24
$0.16
$-0.14
Q3 24
$-0.10
$-0.15
Q2 24
$0.10
$-0.33
Q1 24
$-0.14
$0.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AP
AP
ESPR
ESPR
Cash + ST InvestmentsLiquidity on hand
$10.7M
$167.9M
Total DebtLower is stronger
$117.9M
Stockholders' EquityBook value
$32.6M
$-302.0M
Total Assets
$495.4M
$465.9M
Debt / EquityLower = less leverage
3.61×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AP
AP
ESPR
ESPR
Q4 25
$10.7M
$167.9M
Q3 25
$15.0M
$92.4M
Q2 25
$9.9M
$86.1M
Q1 25
$7.1M
$114.6M
Q4 24
$15.4M
$144.8M
Q3 24
$11.8M
$144.7M
Q2 24
$7.9M
$189.3M
Q1 24
$10.8M
$226.6M
Total Debt
AP
AP
ESPR
ESPR
Q4 25
$117.9M
Q3 25
$119.0M
Q2 25
$115.9M
Q1 25
$115.0M
Q4 24
$116.4M
Q3 24
$116.0M
Q2 24
$119.4M
Q1 24
$116.2M
Stockholders' Equity
AP
AP
ESPR
ESPR
Q4 25
$32.6M
$-302.0M
Q3 25
$60.1M
$-451.4M
Q2 25
$62.7M
$-433.5M
Q1 25
$64.6M
$-426.2M
Q4 24
$58.9M
$-388.7M
Q3 24
$61.3M
$-370.2M
Q2 24
$58.0M
$-344.2M
Q1 24
$56.3M
$-294.3M
Total Assets
AP
AP
ESPR
ESPR
Q4 25
$495.4M
$465.9M
Q3 25
$524.4M
$364.0M
Q2 25
$537.2M
$347.1M
Q1 25
$536.2M
$324.0M
Q4 24
$530.9M
$343.8M
Q3 24
$547.4M
$314.1M
Q2 24
$560.8M
$352.3M
Q1 24
$565.8M
$373.1M
Debt / Equity
AP
AP
ESPR
ESPR
Q4 25
3.61×
Q3 25
1.98×
Q2 25
1.85×
Q1 25
1.78×
Q4 24
1.98×
Q3 24
1.89×
Q2 24
2.06×
Q1 24
2.06×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AP
AP
ESPR
ESPR
Operating Cash FlowLast quarter
$2.7M
$45.2M
Free Cash FlowOCF − Capex
$-64.0K
FCF MarginFCF / Revenue
-0.1%
Capex IntensityCapex / Revenue
2.7%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-8.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AP
AP
ESPR
ESPR
Q4 25
$2.7M
$45.2M
Q3 25
$6.3M
$-4.3M
Q2 25
$-2.3M
$-31.4M
Q1 25
$-5.3M
$-22.6M
Q4 24
$7.5M
$-35.0M
Q3 24
$11.4M
$-35.3M
Q2 24
$-5.3M
$-7.2M
Q1 24
$4.5M
$53.8M
Free Cash Flow
AP
AP
ESPR
ESPR
Q4 25
$-64.0K
Q3 25
$3.3M
Q2 25
$-3.8M
Q1 25
$-7.5M
Q4 24
$3.7M
Q3 24
$8.4M
$-35.5M
Q2 24
$-8.0M
$-7.3M
Q1 24
$1.7M
$53.8M
FCF Margin
AP
AP
ESPR
ESPR
Q4 25
-0.1%
Q3 25
3.2%
Q2 25
-3.5%
Q1 25
-7.5%
Q4 24
4.0%
Q3 24
9.1%
-68.7%
Q2 24
-7.5%
-9.9%
Q1 24
1.5%
39.0%
Capex Intensity
AP
AP
ESPR
ESPR
Q4 25
2.7%
0.0%
Q3 25
2.9%
0.0%
Q2 25
1.3%
0.0%
Q1 25
2.2%
0.0%
Q4 24
4.0%
0.0%
Q3 24
3.2%
0.3%
Q2 24
2.5%
0.1%
Q1 24
2.6%
0.1%
Cash Conversion
AP
AP
ESPR
ESPR
Q4 25
Q3 25
Q2 25
Q1 25
-4.62×
Q4 24
2.40×
Q3 24
Q2 24
-2.64×
Q1 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AP
AP

Forged And Cast Mill Rolls$67.0M64%
Air Handling Systems$14.3M14%
Heat Exchange Coils$13.1M13%
Centrifugal Pumps$10.3M10%
Forged Engineered Products$4.0M4%

ESPR
ESPR

Collaboration Revenue$124.7M74%
Products$43.7M26%

Related Comparisons